Application of Amyloid PET in Cerebral Amyloid Angiopathy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 160 participants.
Also called NCT03542656
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 3
- Enrolled
- 160 participants
- Registry
-
NCT03542656
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Taiwan
- Registry status
- Completed
Technical summary
Registry record NCT03542656. Allocation not applicable; no masking; primary purpose diagnostic. Start 2014-09-11 (actual); primary completion 2016-02-17 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Application of Amyloid PET in Cerebral Amyloid Angiopathy
- Acronym
- CAA
- Condition
- Cerebral Amyloid Angiopathy
- Condition
- Intracranial Hemorrhages
- Condition
- Alzheimer Disease
- Intervention (Drug)
- amyloid PET
- Lead sponsor
- National Taiwan University Hospital
Record details
- Record id
cardio:ct-nct03542656- Content hash
559a406d6bfdc956676629348e892500578d03e736eb4a3f9733fc8ee5ed1b4b